Skip to main content

Aggressive Breast Cancer Responds to New Drug

woman looking at mamagram image

In the clinical trial of the new drug, sacituzumab govitecan, about a third of the patients responded to treatment and the effect lasted up to eight months. The research was funded by the drug's maker.



from WebMD Health https://ift.tt/2EnqLcY
via IFTTT

Comments

Popular posts from this blog

Health Anxiety Common as COVID Restrictions Loosen

As restrictions lift and mask mandates become scarce, Americans are filling their social calendars and booking vacations. While some are rejoicing, health care professionals say others are emerging from the pandemic with more health-related fears. from WebMD Health https://ift.tt/3yZdxwA via IFTTT

Is Your Pelvic Pain a Sign of Endometriosis?

Women are most likely to develop endometriosis between the ages of 25 and 50, and it may contribute to reduced fertility. Left untreated for years, endometriosis can result in debilitating nerve pain. from WebMD Health https://ift.tt/2LtFXc8 via IFTTT

AGENTS OF CHANGE

Its propensity to provoke thought and challenge the status quo sets Goa-based Theatre Flamingo apart. Verve talks to three core members to find out how the troupe is opening up dialogues around sociocultural issues and tenaciously driving change in their state through theatre and the grassroots initiatives built around it The post AGENTS OF CHANGE first appeared on Verve Magazine . from Verve Magazine https://ift.tt/G5NnEyw